Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia
Clinical trial NCT01503359 · COMPLETED
Trial details
- NCT number
- NCT01503359
- Sponsor
- Medical University of Lodz
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2015-02-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.